GSK

A Note On 23andMe’s New Collaboration with GSK

July 25, 2018
23andMe announces the launch of a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make meaningful discoveries in therapeutics to treat disease.
Read More

New Genetic Associations for Rosacea Found

July 05, 2018
A new study found that seven gene regions associated with the chronic skin condition, rosacea, also play a role in skin pigmentation, immune response, and inflammation. The findings give new insight into the underlying biology of the disease and may hold clues for identifying drug targets used to treat it, according to the researchers at GlaxoSmithKline who collaborated with 23andMe to conduct the study.
Read More